Hubei Guangji Pharmaceutical Co.,Ltd.’s Net Profit Dropped 74.2% in First Three Quarters of 2022

Hubei Guangji Pharmaceutical Co.,Ltd. (湖北广济药业股份有限公司) (000952.SZ) reported a net profit of 18.3 million yuan in the first three quarters of 2022, down 74.2% year-on-year.

Meanwhile, the company posted 536.3 million yuan in revenue, up 12.6% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 893.1 million yuan in total liabilities, with a liability-to-asset ratio of 38%.